Novo Nordisk A/S — Quarterly Financial Data (NYSE:NVO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends Documents

Quarterly Annual

Dividends per share — — Dividend yield % — — Payout ratio % — —

News

Opinion: Plastic surgery is booming with boomers. Here’s how to cash in on the antiaging craze.

AMGN's MariTide: Can Convenience Drive its Obesity Market Share?

Oura files for IPO amid Americans’ obsession with tracking their sleep, steps and heart rates

Pfizer's Pipeline Strategy Centers on Obesity and Oncology

HIMS Raises 2026 Revenue Outlook as Q2 Sales Rise 38.2% Despite Loss

Fraudulent Weight Loss Drugs: FDA Warns Against Mislabeled GLP-1 Medications - Hims & Hers Health (NYSE:H

GSK Stock Down 14% in Six Months: Time to Buy, Hold or Exit?

Trump Expands Drug Pricing Agreements With 9 Drugmakers— RFK Jr. Says President Called ‘Every Hour’ to En

Trump Admin To Target Biotechs With Curbs On Drug Pricing? What Investors Should Know

LLY's Mounjaro Gets FDA Nod to Cut Cardiovascular Risk in Diabetes

Can CagriSema Help Novo Nordisk Close the Gap With LLY in Obesity?

Novo Nordisk: Why The Price Remains Stubbornly Low (Rating Downgrade) (NYSE:NVO)